Ad-hoc | 12 February 2017 22:14
STADA Arzneimittel AG / Key word(s): Miscellaneous
12-Feb-2017 / 22:14 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Bad Vilbel, February 12, 2017 - Due to market rumours, STADA Arzneimittel
AG confirms that it has received two legally non-binding expressions of
interest regarding a bid for the acquisition of up to 100 percent of the
shares in the Company, one of which is from Cinven Partners LLP at an
indicative takeover price of Euro 56.00 per STADA share. STADA is currently
weighing up its options on how to react in the best interest of the
Company. It is not yet possible to foresee whether a takeover offer from
Cinven or the other potential bidder will indeed materialise. STADA will
keep both the capital markets and the public updated on tangible
development in this regard, in line with the applicable legal requirements.
Contact:
STADA Arzneimittel AG / Investor Relations / Leslie Iltgen / Stadastraße 2-
18 / 61118 Bad Vilbel - Germany / Tel.: +49 (0) 6101 603-173 / Fax: +49 (0)
6101 603-215 / E-mail: leslie.iltgen@stada.de
Or visit us in the Internet at www.stada.com.
---------------------------------------------------------------------------
12-Feb-2017 CET/CEST The DGAP Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
Phone: +49 (0)6101 603- 113
Fax: +49 (0)6101 603- 506
E-mail: communications@stada.de
Internet: www.stada.de
ISIN: DE0007251803, DE0007251845,
WKN: 725180, 725184,
Indices: MDAX
Listed: Regulated Market in Dusseldorf, Frankfurt (Prime
Standard); Regulated Unofficial Market in Berlin, Hamburg,
Hanover, Munich, Stuttgart, Tradegate Exchange
End of Announcement DGAP News Service